IRIS
BARONE, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.226
NA - Nord America 2.190
EU - Europa 1.543
SA - Sud America 325
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 5
Totale 6.349
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.104
SG - Singapore 1.022
RU - Federazione Russa 763
VN - Vietnam 422
CN - Cina 414
BR - Brasile 265
HK - Hong Kong 170
DE - Germania 141
FI - Finlandia 112
IT - Italia 105
FR - Francia 87
NL - Olanda 77
IE - Irlanda 65
UA - Ucraina 60
GB - Regno Unito 54
CA - Canada 45
SE - Svezia 38
MX - Messico 31
IN - India 30
AR - Argentina 25
JP - Giappone 22
IQ - Iraq 18
PH - Filippine 18
ZA - Sudafrica 16
BD - Bangladesh 15
TR - Turchia 14
ES - Italia 13
CI - Costa d'Avorio 12
ID - Indonesia 12
TH - Thailandia 11
PL - Polonia 10
EC - Ecuador 9
PK - Pakistan 8
CO - Colombia 7
JO - Giordania 7
VE - Venezuela 7
DZ - Algeria 5
IL - Israele 5
MA - Marocco 5
UZ - Uzbekistan 5
EG - Egitto 4
EU - Europa 4
KR - Corea 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
KE - Kenya 3
KZ - Kazakistan 3
MD - Moldavia 3
SA - Arabia Saudita 3
TN - Tunisia 3
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GM - Gambi 2
GT - Guatemala 2
KG - Kirghizistan 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
SN - Senegal 2
TL - Timor Orientale 2
YE - Yemen 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
BS - Bahamas 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
MY - Malesia 1
PE - Perù 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TJ - Tagikistan 1
TW - Taiwan 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.349
Salva come PNG Salva come JPEG
Città #
Singapore 455
San Jose 262
Moscow 178
Chandler 170
Santa Clara 159
Ashburn 154
Hong Kong 151
Beijing 132
Ho Chi Minh City 125
Jacksonville 100
Hanoi 93
Los Angeles 79
Millbury 73
Amsterdam 70
Princeton 70
The Dalles 63
Lauterbourg 60
Nanjing 60
Munich 47
Boston 45
Dallas 34
Wilmington 30
Buffalo 29
Nanchang 29
New York 28
Seattle 26
São Paulo 25
Helsinki 22
Turku 21
Ottawa 20
Da Nang 19
Frankfurt am Main 19
Redondo Beach 19
Houston 17
Tokyo 17
Mexico City 16
Naples 15
Norwalk 15
Washington 15
Rome 14
Haiphong 13
Columbus 12
Atlanta 11
Boardman 11
Brooklyn 11
Council Bluffs 11
Ankara 10
Baghdad 10
Chicago 10
Denver 10
Kunming 10
Montreal 10
Stockholm 10
Belo Horizonte 9
Falkenstein 9
London 9
Napoli 9
Orem 9
Shanghai 9
Pune 8
Brasília 7
Chennai 7
Falls Church 7
Hải Dương 7
Jiaxing 7
Shenyang 7
Thái Bình 7
Tianjin 7
Miami 6
San Francisco 6
Toronto 6
Amman 5
Biên Hòa 5
Can Tho 5
Hangzhou 5
Manchester 5
Phoenix 5
Poplar 5
Rio de Janeiro 5
Tashkent 5
Bexley 4
Buon Ma Thuot 4
Catania 4
Changsha 4
Dublin 4
Hebei 4
Hefei 4
Karachi 4
Kronberg 4
Montevideo 4
Nuremberg 4
Porto Alegre 4
Santo André 4
Secaucus 4
Tampa 4
Vinh 4
Warsaw 4
Ann Arbor 3
Bangkok 3
Basra 3
Totale 3.373
Salva come PNG Salva come JPEG
Nome #
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease. 163
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 154
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 151
Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial 141
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 137
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 135
Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients 129
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 120
Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism. 120
Freezing of gait and executive functions in patients with Parkinson's disease. 119
Diffusion-weighted imaging in multiple system atrophy: a comparison between clinical subtypes. 117
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2. 115
PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. 115
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. 112
No evidence of association between CAG expansions and essential tremor in a large cohort of italian patients 110
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. 109
RNA analysis of consensus sequence splicing mutations: implications for the diagnosis of Wilson disease. 108
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms 105
Nitric oxide-hemoglobin interaction: a new biochemical hypothesis for signal changes in fMRI 103
Dopamine agonist-based strategies in the treatment of Parkinson's disease. 102
Is arginine test a reliable tool for differential diagnosis of multiple system atrophy? 102
Parkinsonism and essential tremor in a family with pseudo-dominant inheritance of PARK2: an FP-CIT SPECT study. 101
Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. 100
Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. 96
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 96
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 96
Frontal dysfunction contributes to the genesis of hallucinations in non-demented Parkinsonian patients. 95
Perspectives on recent advances in the understanding and treatment of Parkinson's disease. 95
Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia. 94
The PRIAMO study: background, methods and recruitment. 92
HOMER1 promoter analysis in Parkinson's disease: association study with psychotic symptoms. 92
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. 91
Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT. 88
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions. 88
Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test 87
Depression rating scales in Parkinson's disease: critique and recommendations. 87
Linkage exclusion in Italian families with hereditary essential tremor. 87
Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. 86
HOMER1 promoter analysis in parkinson's disease: association study with psychotic symptoms 86
Clinical and neurological abnormalities in adult celiac disease. 82
Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients. 81
Dopa-responsive pseudo-orthostatic tremor in parkinsonism. 81
Nitrite- and peroxide-dependent oxidation pathways of dopamine: 6-nitrodopamine and 6-hydroxydopamine formation as potential contributory mechanisms of oxidative stress- and nitric oxide-induced neurotoxicity in neuronal degeneration 79
Dopamine receptor agonists and depression in Parkinson's disease. 77
Dopamine mediated responses in 6-OH-DA lesioned rats involve changes of the signal transduction. 76
Subclinical sensory abnormalities in unaffected PINK1 heterozygotes. 76
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 75
International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. 75
Red flags for multiple system atrophy. 75
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire. 74
Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. 74
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 74
No evidence of association between CAG expansions and essential tremor in a large cohort of italian patients 73
COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson's disease (PD): relevance for motor and non-motor features. 72
The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. 72
Pergolide monotherapy in the treatment of early PD. A randomized, controlled study. 71
Amitriptyline as a prophylactic for migraine in children. 70
Behavioural sensitization in 6-OHDA lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB-related and JunD-related proteins 70
The status of dopamine nerve terminals in Parkinson\'s disease and essential tremor: a PET study with the tracer [11-C]FE-CIT. 68
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 66
Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease. 65
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 64
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. 62
Stimulation of growth hormone release in multiple system atrophy, Parkinson's disease and idiopathic cerebellar ataxia. 62
Headache in children, an epidemiological study. 61
Neurotransmission in Parkinson's disease: beyond dopamine. 61
The FRAGAMP study: environmental and genetic factors inParkinson's disease, methods and clinical features. 60
Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG). 56
Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. 54
Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa. 48
null 12
Totale 6.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.689
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 0 19 1
2021/2022319 3 0 0 4 0 9 1 12 67 12 52 159
2022/2023410 73 35 17 25 46 33 0 38 57 66 16 4
2023/2024321 7 38 32 35 27 53 2 32 0 10 73 12
2024/20251.726 101 82 6 9 86 133 174 118 71 170 638 138
2025/20263.020 348 196 306 293 607 109 392 157 382 192 38 0
Totale 6.390